 Three groups of subjects will be studied: lean, healthy control subjects n12 obese non-diabetic subjects n12 and patients with type 2 Diabetes Mellitus n12 for a total of 36 subjects. Twenty subjects have completed the study at Arizona State University; the remaining 16 subjects will be accrued at the Mayo Clinic in Arizona. 